Previous 10 | Next 10 |
Software AG ADR (STWRY) is expected to report for Q2 2023 Dai Nippon Printing Co Ltd ADR (DNPLY) is expected to report for quarter end 2023-06-30 Coffee Holding Co. Inc. (JVA) is expected to report for Q1 2024 Calloway`s Nursery, Inc. (CLWY) is expected to report for Q2 2023 Home ...
Sportsman's Warehouse Holdings Inc. (SPWH) is expected to report $0.02 for Q2 2024 Screen Holdings Co. Ltd. (DINRF) is expected to report for Q1 2024 Bionik Laboratories Corp (BNKL) is expected to report for Q1 2024 Atento S.A. (ATTOF) is expected to report for Q2 2023 Akoustis Te...
Bionik Laboratories Corp (BNKL) is expected to report for Q1 2024
The completed installations in Arizona, California, Indiana, and Kentucky will bring advance stroke recovery care to Lifepoint Health patients. Bionik Laboratories Corp. (OTCPINK: BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recovery solutions ...
Bionik’s first neuro-specialized rehabilitation clinic at Tower Physical Therapy & Rehab records significant patient growth, Bionik in advanced discussions regarding additional potential acquisitions Bionik Laboratories Corp . (OTCPINK: BNKL) , a robotics company ...
The agreement allows Bionik to further expand its footprint in Asia through Pro-Med’s sales and distribution network across Hong Kong Bionik Laboratories Corp . (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and ot...
Through the Company’s continued work with Curexo, its exclusive distribution partner for South Korea, Bionik will be featured as part of the show’s focus on the future of the medical industry Bionik Laboratories Corp . (OTCPINK: BNKL), a robotics company providing neur...
Bionik Laboratories press release ( OTCPK:BNKL ): Q3 Non-GAAP EPS of -$0.15. Revenue of $0.57M (+216.7% Y/Y). For further details see: Bionik Laboratories Non-GAAP EPS of -$0.15, revenue of $0.57M
Nine Month Shipments and Revenue Exceeds 12-month Results of Prior Fiscal Year Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, offering its technolo...
Bionik Laboratories press release ( OTCPK:BNKL ): Q2 GAAP EPS of -$0.16. Revenue of $0.49M (+113.0% Y/Y). For further details see: Bionik Laboratories GAAP EPS of -$0.16, revenue of $0.49M
News, Short Squeeze, Breakout and More Instantly...
Bionik Laboratories Corp Company Name:
BNKL Stock Symbol:
OTCMKTS Market:
Bionik Laboratories Corp Website:
Sportsman's Warehouse Holdings Inc. (SPWH) is expected to report $-0.3 for Q4 2024 IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2024-01-31 Klepierre (KLPEF) is expected to report for Q4 2023 Steakholder Foods Ltd. (STKH) is expected to report for Q4 2023 R...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Weir Group plc ADR (WEGRY) is expected to report for Q4 2023 So-Young International Inc. (SY) is expected to report for quarter end 2023-12-31 Atara Biotherapeutics Inc. (ATRA) is expected to report $-0.61 for Q4 2023 Adyen NV ADR (ADYEY) is expected to report for Q4 2023 Five Bel...